Proposed Local Coverage Determination (LCD) - MolDX: Signatera™ and MinimalResidual Disease Testing for Colorectal Cancer (DL38290)

Nov 20

Written By Laura Tramontozzi

Laura Tramontozzi

Medicare Coverage of Innovative Technology & Definition of “Reasonable & Necessary”

MolDX Local Coverage Determination (DL38043)